These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
21. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686 [TBL] [Abstract][Full Text] [Related]
22. Marrow transplantation in the treatment of acute leukemia. Thomas ED; Buckner CD; Fefer A; Neiman PE; Storb R Adv Cancer Res; 1978; 27():269-79. PubMed ID: 28643 [No Abstract] [Full Text] [Related]
23. Immunocompetence following allogeneic bone marrow transplantation in man. Halterman RH; Graw RG; Fuccillo DA; Leventhal BG Transplantation; 1972 Dec; 14(6):689-97. PubMed ID: 4404985 [No Abstract] [Full Text] [Related]
24. Marrow transplantation for aplastic anemia and acute leukemia. Neiman P; Thomas ED; Buckner CD; Storb R; Fefer A; Glucksberg H; Lerner KG Annu Rev Med; 1974; 25():179-98. PubMed ID: 4150980 [No Abstract] [Full Text] [Related]
25. Relapse of host leukemic lymphoblasts following engraftment by an HLA-mismatched marrow transplant: mechanisms of escape from the "graft versus leukemia" effect. Sondel PM; Hank JA; Molenda J; Blank J; Borcherding W; Longo W; Trigg ME; Hong R; Bozdech MJ Exp Hematol; 1985 Sep; 13(8):782-90. PubMed ID: 2931298 [TBL] [Abstract][Full Text] [Related]
26. Bone marrow transplantation with intensive combination chemotherapy/radiation therapy (SCARI) in acute leukemia. The UCLA Bone Marrow Transplantation Group Ann Intern Med; 1977 Feb; 86(2):155-61. PubMed ID: 13696 [TBL] [Abstract][Full Text] [Related]
27. Bone marrow transplantation between mixed lymphocyte culture-reactive individuals. Gale RP; Opelz G; Sparkes R Transplantation; 1975 Sep; 20(3):194-7. PubMed ID: 125939 [TBL] [Abstract][Full Text] [Related]
28. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF. Chen HR; Ji SQ; Wang HX; Yan HM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):340-6. PubMed ID: 12513770 [TBL] [Abstract][Full Text] [Related]
29. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [TBL] [Abstract][Full Text] [Related]
30. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation. Russell CA Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093 [TBL] [Abstract][Full Text] [Related]
31. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies. Champlin R; Gale RP Semin Hematol; 1987 Jan; 24(1):55-67. PubMed ID: 3547673 [TBL] [Abstract][Full Text] [Related]
32. Bone marrow transplantation for acute leukaemia and severe marrow aplasia: an analysis of five patients. Beard ME; Heaton DC; Hamer JW; Watson J; Fox HW; Crosier PS; Abbott GD N Z Med J; 1981 Oct; 94(693):249-52. PubMed ID: 7033845 [TBL] [Abstract][Full Text] [Related]